Congenital adrenal hyperplasia: Transitional care

Growth Hormone and IGF Research

Volumn 14, Issue SUPPL. A, 2004, Pages

  Hughes, Ieuan A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Congenital adrenal hyperplasia; Fertility; Puberty; Testicular tumours

Indexed keywords

CORTISONE ACETATE; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID; HYDROCORTISONE;

ADOLESCENT; ADRENAL CORTEX TUMOR; ADULT; ADULTHOOD; CHILD GROWTH; CHILDHOOD; CONGENITAL ADRENAL HYPERPLASIA; FEMALE; GROUPS BY AGE; GROUPS BY SEX; GROWTH RETARDATION; HEALTH CARE NEED; HORMONE SUBSTITUTION; HUMAN; INFANCY; INFERTILITY; INSULIN RESISTANCE; LEYDIG CELL TUMOR; MALE; METABOLIC DISORDER; OBESITY; OVARY POLYCYSTIC DISEASE; PATIENT CARE; PEDIATRICIAN; PRIORITY JOURNAL; REVIEW; SCHOOL CHILD; TURNER SYNDROME;

EID: 2542613657     PISSN: 10966374     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ghir.2004.03.015     Document Type: Review

References (57)

1. I.A. Hughes, Congenital adrenal hyperplasia - a continuum of disorders, Lancet 352 (1998) 752-754.
2. F.G. Riepe, N. Krone, M. Viemann, C.-J. Partsch, W.G. Sippell, Management of congenital adrenal hyperplasia: results of the ESPE questionnaire, Horm. Res. 58 (2002) 196-205.
3. I.A. Hughes, Congenital adrenal hyperplasia: phenotype and genotype, J. Ped. Endocrinol. Metab. 15 (2002) 1329-1340.
4. J.W. Honour, T. Torresani, Evaluation of neonatal screening for congenital adrenal hyperplasia, Horm. Res. 55 (2001) 206-211.
5. P.C. White, P.W. Speiser, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Endocr. Rev. 21 (2000) 245-291.
6. P.D. Stenson, E.V. Ball, M. Mort, A.D. Phillips, J.A. Shiel, N.S. Thomas, S. Abeysinghe, M. Krawczak, D.N. Cooper, Human Gene Mutation Database (HGMD (R)): 2003 update, Hum. Mutat 21 (2003) 577-581.
7. C. Moran, R. Azziz, E. Carmina, D. Dewailly, F. Fruzzetti, L. Ibanez, E.S. Knochenhauer, J.A. Marcondes, B.B. Mendonca, D. Pignatelli, M. Pugeat, V. Rohmer, P.W. Speiser, S.F. Witchel, 21-Hydroxylase-deficient nonclasssical adrenal hyperplasia is a progressive disorder: a multicenter study, Am. J. Obstet. Gynecol. 183 (2000) 1468-1474.
8. M. Diamond, Pediatric management of ambiguous and traumatized genitalia, J. Urol. 162 (1999) 1021-1028.
9. S. Creighton, C. Minto, Managing intersex, Br. Med. J. 323 (2001) 1264-1265.
10. S.M. Creighton, C.L. Minto, S.J. Steele, Objective cosmetic and anatomical outcomes at adolescence of feminising surgery for ambiguous genitalia done in childhood, Lancet 358 (2001) 124-125.
11. L.S. Baskin, A. Erol, Y.W. Li, W.H. Liu, E. Kurzrock, G.R. Cunha, Anatomical studies of the human clitoris, J. Urol. 162 (1999) 1015-1020.
12. C.L. Minto, L.-M. Liao, C.R.J. Woodhouse, P.G. Ransley, S.M. Creighton, The effect of clitoral surgery on sexual outcome in individuals who have intersex conditions with ambiguous genitalia: a cross-sectional study, Lancet 361 (2003) 1252-1257.
13. S.A. Rivkees, J.D. Crawford, Dexamethasone treatment of virilizing congenital adrenal hyperplasia: the ability to achieve normal growth, Pediatrics 106 (2000) 767-773.
14. B.L. Linder, N.V. Esteban, A.L. Yergey, J.C. Winterer, D.L. Loriaux, F. Cassorla, Cortisol production rate in childhood and adolescence, J. Pediatr. 117 (1990) 892-896.
15. M.C. Young, N. Cook, G.F. Read, I.A. Hughes, The pharmacokinetics of low-dose dexamethasone in congenital adrenal hyperplasia, Eur. J. Clin. Pharmacol. 37 (1989) 75-77.
16. P.W. Speiser, P.C. White, Medical progress. Congenital adrenal hyperplasia, New Engl. J. Med. 349 (2003) 776-788.
17. M.C. Young, J.A. Robinson, G.F. Read, D. Riad-Fahmy, I.A. Hughes, 17-Hydroxyprogesterone rhythms in congenital adrenal hyperplasia, Arch. Dis. Child 63 (1988) 617-623.
18. H.H. Bode, S.A. Rivkees, D.M. Cowley, K. Pardy, S. Johnson, Home monitoring of 17-hydroxyprogesterone levels in congenital adrenal hyperplasia with filter paper blood samples, J. Pediatr. 134 (1999) 185-189.
19. E.A. Eugster, L.A. DiMeglio, J.C. Wright, G.R. Freidenberg, R. Seshadri, O.H. Pescovitz, Height outcome in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a meta-analysis, J. Pediatr. 138 (2001) 26-32.
20. L.D. Premawardhana, I.A. Hughes, G.F. Read, M.F. Scanlon, Longer term outcome in females with congenital adrenal hyperplasia (CAH): the Cardiff experience, Clin. Endocrinol. 46 (1997) 327-332.
21. I. Manoli, C.R. Kanaka-Gantenbeing, A. Voutetakis, M. Maniati-Christidi, C. Dacon-Voutetakis, Early growth, pubertal development body mass index and final height of patients with congenital adrenal hyperplasia: factors influencing the outcome, Clin. Endocrinol. 57 (2002) 669-676.
22. N.M. Stikkelbroeck, A.R. Hermus, D.D. Broat, B.J. Otten, Fertility in women with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, Obstet. Gynecol. Surv. 58 (2003) 275-284.
23. C.-J. Partsch, S. Heger, W.G. Sippell, Management and outcome of central precocious puberty, Clin. Endocrinol. 56 (2002) 129-148.
24. S.L. Kaplan, M.M. Grumbach, Clinical review 14: Pathophysiology and treatment of sexual precocity, J. Clin. Endocrinol. Metab. 71 (1990) 785-789.
25. J.B. Quintos, M.G. Vogiatzi, M.D. Harbison, M.I. New, Growth hormone therapy alone or in combination with gonadotropin-releasing hormone analogue therapy to improve the height deficit in children with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 86 (2001) 1511-1517.
26. M. Hines, Abnormal sexual development and psychosexual issues, Baillières Clin. Endocrinol. Metab. 12 (1998) 173-189.
27. H.F. Meyer-Bahlburg, Gender and sexuality in classic congenital adrenal hyperplasia, Endocrinol. Metab. Clin. North Am. 30 (2001) 165-171.
28. S.A. Berenbaum, J.M. Bailey, Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 88 (2003) 1102-1106.
29. E. Charmandari, P.C. Hindmarsh, A. Johnson, C.G.D. Brook, Congenital adrenal hyperplasia due to21-hydroxylase deficiency: alterations in cortisol pharmacokinetics at puberty, J. Clin. Endocrinol. Metab. 86 (2001) 2701-2708.
30. R.E. Cornean, P.C. Hindmarsh, C.G.D. Brook, Obesity in 21-hydroxylase deficient patients, Arch. Dis. Child 78 (1998) 261-263.
31. E. Charmandari, M. Weise, S.R. Bornstein, G. Eisenhofer, M.F. Keil, G.P. Chrousos, D.P. Merke, Children with classic congenital adrenal hyperplasia have elevated serum leptin concentrations and insulin resistance: potential clinical applications, J. Clin. Endocrinol. Metab. 87 (2002) 2114-2120.
32. D.P. Merke, G.P. Chrousos, G. Eisenhofer, M. Weise, M.F. Keil, A.D. Rogol, J.J. Van Wyk, S.R. Bornstein, Adrenomedullary dysplasia and hypofunction in patients with classic 21-hydroxylase deficiency, New Engl. J. Med. 343 (2000) 1362-1368.
33. J. Jääskeläinen, R. Voutilainen, Bone mineral density in relation to glucocorticoid substitution therapy in adult patients with 21-hydroxylase deficiency, Clin. Endocrinol. 45 (1996) 707-713.
34. K. Hagenfelt, E.M. Ritzen, H. Ringertz, J. Helleday, K. Carlstrom, Bone mass and body composition of adult women with congenital virilizing 21-hydroxylase deficiency after glucocorticoid treatment since infancy, Eur. J. Endocrinol. 143 (2000) 667-671.
35. C.Y. Gus, A.P. Weetman, R. Eastell, Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia, Clin. Endocrinol. 45 (1996) 535-541.
36. O. Arisaka, M. Hoshi, S. Kanazawa, M. Numata, D. Nakajima, S. Kanno, M. Negishi, K. Nishikura, A. Nitta, M. Imataka, T. Kuribayashi, K. Kano, Preliminary report: effect of adrenal androgen and estrogen on bone maturation and bone mineral density, Metabolism 50 (2001) 377-379.
37. N.M.M.L. Stikkelbroeck, W.J.G. Oyen, G.-J. Van der Wilt, A.R.M.M. Hermus, B.J. Otten, Normal bone mineral density and lean body mass but increased fat mass in young adult patients with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 88 (2003) 1036-1042.
38. L. Wilkins, W. Fleighmann, J.E. Howard, Macrogenitosomia precox associated with hyperplasia of the androgenic tissue of the adrenal and death from corticoadrenal insufficiency, Endocrinology 26 (1940) 295-385.
39. J.L. Rutgess, R.H. Young, R.E. Scully, The testicular tumor of the adrenogenital syndrome. A report of six cases and review of the literature on testicular masses in patients with adrenocortical disorders, Am. J. Surg. Pathol. 12 (1988) 503-513.
40. M.A. Rich, M.A. Keating, Leydig cell tumor and tumors associated with congenital adrenal hyperplasia, Urol. Clinics N. Am. 27 (2000) 519-528.
41. M.S. Srikanth, B.R. West, M. Ishitani, H. Isaacs Jr., H. Applebaum, G. Costin, Benign testicular tumours in children with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 86 (2001) 5721-5728.
42. M. Jain, H.M. Aiyer, P. Bajaj, S. Dhar, Intracytoplasmic and intranuclear Reinke's crystals in a testicular Leydig-cell tumour diagnosed by fine-needle aspiration cytology: a case report with review of the literature, Diagn. Cytopathol. 25 (2001) 162-164.
43. N.M.M.L. Stikkelbroeck, H.M. Suliman, B.J. Otten, A.R.M.M. Hermus, J.G. Blickman, G.J. Jager, Testicular adrenal rest tumours in postpubertal males with congenital adrenal hyperplasia: sonographic and MR features, Eur. Radiol. 13 (2003) 1597-1603.
44. N.M.M.L. Stikkelbroeck, A.R.M.M. Hermus, H.M. Suliman, G.J. Jager, B.J. Otten, Asymptomatic testicular adrenal rest tumours in adolescent and adult males with congenital adrenal hyperplasia: basal and follow-up investigation after 2.6 years, J. Pediatr. Endocrinol. Metab., in press.
45. C.E. Keegan, G.D. Hammer, Recent insights into organogenesis of the adrenal cortex, Trends Endocrinol. Metab 13 (2002) 200-208.
46. C. Wylie, Germ cells, Cell 96 (1999) 165-174.
47. K. Morshashi, The ontogenesis of the steroidogenic tissues, Genes Cells 2 (1997) 95-106.
48. K. Jeays-Ward, C. Hoyle, J. Brennan, M. Dandonneau, G. Alldus, B. Capel, A. Swain, Endothelial and steroidogenic cell migration are regulated by WNT4 in the developing mammalian gonad, Development 130 (2003) 3663-3670.
49. J. Jääskeläinen, O. Kiekara, M. Hippelainen, R. Voutilainen, Pituitary gonadal axis and child rate in males with classical 21-hydroxylase deficiency, J. Endocrinol. Invest. 23 (2000) 23-27.
50. N.M. Stikkelbroeck, B.J. Otten, A. Pasic, G.J. Jager, C.G. Sweep, K. Noordam, A.R. Hermus, High prevalence of testicular adrenal rest tumours impaired spermatogenesis and Leydig cell failure in adolescent and adult males with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 86 (2001) 5721-5728.
51. G.E. Richards, M.M. Grumbach, S.L. Kaplan, F.A. Conte, The effect of long acting glucocorticoids on menstrual abnormalities in patients with virilizing congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 47 (1978) 1208-1215.
52. I.A. Hughes, G.F. Read, Menarche and subsequent ovarian function in girls with congenital adrenal hyperplasia, Horm. Res. 16 (1982) 100-106.
53. D.P. Merke, M.F. Keil, J.V. Jones, J. Fields, S. Hill, G.B. Cutler Jr., Flutamide testolactone and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 85 (2000) 1114-1120.
54. J.J. Van Wyk, D.F. Gunther, E.M. Ritzen, A. Wedell, G.B. Cutler Jr., C.J. Migeon, M.I. New, The use of adrenalectomy as a treatment for congenital adrenal hyperplasia, J. Clin. Endocrinol. Metab. 81 (1996) 3180-3190.
55. R.L. Meyers, J.R. Grua, Bilateral laparoscopic adrenalectomy: a new treatment for difficult cases of congenital adrenal hyperplasia, J. Pediatr. Surg. 35 (2000) 1586-1590.
56. E.M. Gurnell, V.K. Chatterjee, Dehydroepiandrosterone replacement therapy, Eur. J. Endocrinol. 145 (2001) 103-106.
57. A. Fox, Physicians as barriers to successful transitional care, Int. J. Adolesc. Med. Health 14 (2002) 3-7.